Jasmine Zhong appointed Chief Financial Officer of BIAL
BIAL, an innovative pharmaceutical company, has just announced the appointment of Jasmine Zhong as an Executive Board Member, with the role of Chief Financial Officer, starting in November 2025.
Jasmine Zhong succeeds José Redondo, who stepped down from executive functions after 39 years of service to the company. Having made an undeniable contribution to the development, internationalisation, and consolidation of BIAL, José Redondo will now join the Board of Directors as a non-executive member.
With over two decades of international experience in leadership positions in the pharmaceutical, consulting, and financial services sectors, Jasmine Zhong currently serves as CFO of Operations & Integration at the London Stock Exchange Group (LSEG), where she leads and drives operational efficiency, investment governance, and finance partnership for group transformation.
Before joining LSEG, Jasmine Zhong spent 17 years at the pharmaceutical company AstraZeneca, where she held roles such as CFO of AstraZeneca Asia in Singapore, VP of Finance at AstraZeneca Innovative Medicines in Cambridge, UK, and CFO and VP for AstraZeneca China & Hong Kong, in addition to earlier roles in business finance and compliance in Shanghai.
António Horta-Osório, Chairman of BIAL, comments, "We are pleased to welcome Jasmine to the Board of Directors as the new CFO of BIAL. Her extensive experience in the financial sector, with a strong operational focus and investment expertise, will be particularly relevant at this stage of BIAL's life, where innovation and the consolidation of our presence in key international markets are the company's strategic priorities." António Horta-Osório also adds, "It is equally a privilege to continue to count on the experience and deep knowledge of José Redondo, now as a non-executive member of the Board of Directors, after a career marked by extreme dedication and excellence that defines BIAL's history."
Jasmine Zhong emphasises, "I am very excited to take on this new role and to work with the entire BIAL team, ensuring that the financial strategy creates value for stakeholders and aligns with its ambitious vision of improving patients' lives worldwide."
The new CFO of the BIAL group holds an MBA in Accounting and Finance from the University of Georgia's Terry College of Business and a bachelor's degree from Hunan University. Jasmine Zhong has also completed executive education programs at MIT and Stanford-National University of Singapore and is a fellow of the Chartered Institute of Management Accountants.